Telbivudine for the treatment of chronic hepatitis B infection

Telbivudine for the treatment of chronic hepatitis B infection

Bibliographic Details
Main Authors:	D Hartwell, J Jones, P Harris, K Cooper
Format:	Article
Language:	English
Published:	NIHR Journals Library 2009-10-01
Series:	Health Technology Assessment
Online Access:	https://doi.org/10.3310/hta13suppl3/04

Similar Items

Safety and efficacy of telbivudine for the treatment of chronic hepatitis B
by: Melissa K Osborn
Published: (2009-10-01)

Chronic Hepatitis B Treatment: Current Perspectives on Telbivudine
by: Gian Paolo Caviglia, et al.
Published: (2017-12-01)

Telbivudine (Sebivo) in patients with hepatitis B virus (HBV) chronic infection
by: Viola Sacchi
Published: (2008-01-01)

Role of tenofovir and telbivudine in treatment of hepatitis B related acute on chronic liver failure
by: Debraj Malakar, et al.
Published: (2021-01-01)

Comparison of the efficacy of lamivudine and telbivudine in the treatment of chronic hepatitis B: a systematic review
by: Zhao Shushan, et al.
Published: (2010-09-01)

Two cases of telbivudine-induced myopathy in siblings with chronic hepatitis B
by: Eun Hye Kim, et al.
Published: (2013-03-01)

Cost-effectiveness analysis of lamivudine, telbivudine, and entecavir in treatment of chronic hepatitis B with adefovir dipivoxil resistance
by: Wang G, et al.
Published: (2015-06-01)

Effects of Telbivudine Treatment on the Circulating CD4+ T-Cell Subpopulations in Chronic Hepatitis B Patients
by: Yanhua Zheng, et al.
Published: (2012-01-01)

Case report: lactic acidosis and rhabdomyolysis during telbivudine and tenofovir treatment for chronic hepatitis B
by: Yue Ying, et al.
Published: (2018-04-01)

Growth and development of children prenatally exposed to telbivudine administered for the treatment of chronic hepatitis B in their mothers
by: Huihui Zeng, et al.
Published: (2015-04-01)

Comparison of the Effects of Telbivudine and Entecavir Treatment on Estimated Glomerular Filtration Rate in Patients with Chronic Hepatitis B
Published: (2015-11-01)

Efficacy of telbivudine in the treatment of HBeAg negative chronic hepatitis B with normal baseline ALT levels
by: Muhammad Tariq Mehr, et al.
Published: (2012-07-01)

Pegylated interferon/telbivudine sequential therapy in Hepatitis Be antigen negative severe chronic hepatitis B patient
by: Benedetto Caroleo, et al.
Published: (2013-01-01)

DFT/TDDFT calculations of geometry optimization, electronic structure and spectral properties of clevudine and telbivudine for treatment of chronic hepatitis B
by: Dereje Fedasa Tegegn, et al.
Published: (2024-04-01)

Tenofovir disoproxil fumarate for the treatment of chronic hepatitis B infection
by: J Jones, et al.
Published: (2010-05-01)

Tenofovir disoproxil fumarate for the treatment of chronic hepatitis B infection
by: J Jones, et al.
Published: (2010-05-01)

Entecavir+tenofovir vs. lamivudine/telbivudine+adefovir in chronic hepatitis B patients with prior suboptimal response
by: Hyun Young Woo, et al.
Published: (2020-07-01)

Efficacy of 104-week Telbivudine-based optimization strategy in patients with HBeAg-negative chronic hepatitis B virus infections
by: Weiqiang Gan, et al.
Published: (2020-12-01)

Infant immune response to hepatitis B vaccine after fetal exposure to telbivudine
by: Yandi Li, et al.
Published: (2022-01-01)

Comparison of Renal Safety of Tenofovir and Telbivudine in Chronic Hepatitis B Patients: A Real World Study in Indonesia
by: Rino Alvani Gani
Published: (2018-09-01)

Efficacy of telbivudine with conditional tenofovir intensification in patients with chronic hepatitis B: results from the 2-year roadmap strategy
by: Teerha Piratvisuth, et al.
Published: (2016-04-01)

Dynamic analysis of CD127 expression on memory CD8 T cells from patients with chronic hepatitis B during telbivudine treatment
by: Lv Guocai, et al.
Published: (2010-08-01)

Efficacy of telbivudine on interruption of hepatitis B virus vertical transmission: a meta-analysis
by: Min-Hui Liu, et al.
Published: (2013-03-01)

Factors Related to Significant Improvement of Estimated Glomerular Filtration Rates in Chronic Hepatitis B Patients Receiving Telbivudine Therapy
by: Te-Fu Lin, et al.
Published: (2017-01-01)

Telbivudine can safely reduce mother-to-child transmission in chronic hepatitis B women after 12 weeks of gestation
by: Li-fen Han, et al.
Published: (2019-07-01)

Clinical and Immunological Factors Associated with Postpartum Hepatic Flares in Immune-Tolerant Pregnant Women with Hepatitis B Virus Infection Treated with Telbivudine
by: Junfeng Lu, et al.
Published: (2021-11-01)

52-week efficacy and safety of telbivudine with conditional tenofovir intensification at week 24 in HBeAg-positive chronic hepatitis B.
by: Teerha Piratvisuth, et al.
Published: (2013-01-01)

Efficiency of the telbivudine administration in the third trimestr of pregnancy for the prevention of perinatal transmission of hepatitis B virus
by: M. A. Belopolskaya, et al.
Published: (2015-07-01)

Telbivudine Treatment during Late Pregnancy Prevents Mother-to-Child Transmission of Hepatitis B Virus: A Retrospective Study
by: Mengzhi Cai, et al.
Published: (2019-01-01)

Efficacy of telbivudine in Taiwanese chronic hepatitis B patients compared with GLOBE extension study and predicting treatment outcome by HBV DNA kinetics at Week 24
by: Hsu Chao Wei, et al.
Published: (2012-12-01)

Short Term Virologic Efficacies of Telbivudine versus Entecavir against Hepatitis B-Related Hepatocellular Carcinoma
by: Young Woon Kim, et al.
Published: (2015-01-01)

Kinetics of hepatitis B surface antigen and estimated glomerular filtration rate in telbivudine-treated hepatitis B patients with different rescue strategies.
by: Hsien-Chung Yu, et al.
Published: (2020-01-01)

ClinicopathologicalFeatures of telbivudine-associated myopathy
by: Ambang, T., et al.
Published: (2016)

Entecavir for the treatment of chronic hepatitis B infection
by: J Shepherd, et al.
Published: (2009-10-01)

Rhabdomyolysis, lactic acidosis, and multiple organ failure during telbivudine treatment for hepatitis B: a case report and review of the literature
by: Jinxin Zheng, et al.
Published: (2017-11-01)

Clinicopathological Features of Telbivudine-Associated Myopathy.
by: Tomica Ambang, et al.
Published: (2016-01-01)

Adefovir dipivoxil and pegylated interferon alpha for the treatment of chronic hepatitis B: an updated systematic review and economic evaluation
by: J Jones, et al.
Published: (2009-07-01)

A randomized open label trial of tenofovir monotherapy versus tenofovir plus telbivudine in spontaneous reactivation of hepatitis B
by: Ankur Jindal, et al.
Published: (2019-01-01)

THE FIRST EXPERIENCE OF TELBIVUDINE THERAPY IN LIVER TRANSPLANT PATIENTS
by: O. A. Gerasimova, et al.
Published: (2010-06-01)

Telbivudine on IgG-associated hypergammaglobulinemia and TGF-β1 hyperactivity in hepatitis B virus-related liver cirrhosis.
by: Cheng-Hsun Ho, et al.
Published: (2019-01-01)